The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Misuse of Novel Synthetic Opioids: A Deadly New Trend
Open accessAbstract
Novel synthetic opioids (NSOs) include various analogs of fentanyl and newly emerging non-fentanyl compounds. Together with illicitly manufactured fentanyl (IMF), these drugs have caused a recent spike in overdose deaths, whereas deaths from prescription opioids have stabilized. NSOs are used as stand-alone products, as adulterants in heroin, or as constituents of counterfeit prescription medications. During 2015 alone, there were 9580 deaths from synthetic opioids other than methadone. Most of these fatalities were associated with IMF rather than diverted pharmaceutical fentanyl. In opioid overdose cases, where the presence of fentanyl analogs was examined, analogs were implicated in 17% of fatalities. Recent data from law enforcement sources show increasing confiscation of acetylfentanyl, butyrylfentanyl, and furanylfentanyl, in addition to non-fentanyl compounds such as U-47700. Since 2013, deaths from NSOs in the United States were 52 for acetylfentanyl, 40 for butyrylfentanyl, 128 for furanylfentanyl, and 46 for U-47700. All of these substances induce a classic opioid toxidrome, which can be reversed with the competitive antagonist naloxone. However, due to the putative high potency of NSOs and their growing prevalence, it is recommended to forgo the 0.4 mg initial dose of naloxone and start with 2 mg. Because NSOs offer enormous profit potential, and there is strong demand for their use, these drugs are being trafficked by organized crime. NSOs present major challenges for medical professionals, law enforcement agencies, and policymakers. Resources must be distributed equitably to enhance harm reduction though public education, medication-assisted therapies, and improved access to naloxone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Molecular Mechanisms and Regulation of Opioid Receptor Signaling
Law, P.-Y., Wong, Y. H., & Loh, H. H. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.389 · Cited by 661
Mu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578
Gladden, R. M., Martinez, P., & Seth, P. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533a2 · Cited by 426
Vardanyan, R. S., & Hruby, V. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.215 · Cited by 293
Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.
Hawk, K. F., Vaca, F. E., & D’Onofrio, G. (2015) · PubMed Central · Cited by 213
Psychoactive “bath salts”: Not so soothing
Baumann, M. H., Partilla, J. S., & Lehner, K. R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.020 · Cited by 208
Self-citationMohr, A. L. A., Friscia, M., Papsun, D., Kacinko, S. L., Buzby, D., & Logan, B. K. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw086 · Cited by 199
Increases in Fentanyl-Related Overdose Deaths — Florida and Ohio, 2013–2015
Peterson, A. B., Gladden, R. M., Delcher, C., Spies, E., Garcia-Williams, A., Wang, Y., Halpin, J., Zibbell, J., McCarty, C. L., DeFiore-Hyrmer, J., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533a3 · Cited by 188
Kerr, D., Kelly, A., Dietze, P., Jolley, D., & Barger, B. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02724.x · Cited by 175
Cited by
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Opioid crisis: no easy fix to its social and economic determinants
Dasgupta, N., Beletsky, L., & Ciccarone, D. (2018) · American Journal of Public Health · doi:10.2105/ajph.2017.304187 · Cited by 923
Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.08.007 · Cited by 317
Designer drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
New/emerging psychoactive substances and associated psychopathological consequences
Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021) · Psychological Medicine · doi:10.1017/s0033291719001727 · Cited by 119
Metadata
- Authors
- Prekupec, M. P., Mansky, P. A., & Baumann, M. H.
- Venue
- Journal of Addiction Medicine
- Published
- 2017-07
- Volume
- 11
- Issue
- 4
- Pages
- 256-265
- ISSN
- 1932-0620 (ISSN-L)
- 1935-3227
- OpenAlex
- W2622699130
- Cited by
- 283
- References
- 62
- FWCI
- 36.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Misuse of Novel Synthetic Opioids: A Deadly New Trend. https://app.cochat.ai/papers/10.1097/adm.0000000000000324
- The paper
- Prekupec, M. P., Mansky, P. A., & Baumann, M. H. (2017). Misuse of Novel Synthetic Opioids: A Deadly New Trend. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000324
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.